Home / Import refusals / SCS-1068884-6/21/1

FDA Import Refusal SCS-1068884-6/21/1 — Mylan Pharmaceuticals Inc

Mylan Pharmaceuticals Inc — FEI 1110315

The FDA refused shipment SCS-1068884-6/21/1 from Mylan Pharmaceuticals Inc (United States) on August 14, 2020. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
August 14, 2020
Country
United States
Product Category
Drugs and Biologics
Product Code
66VDA99 MISCELLANEOUS PATENT MEDICINES, ETC.
Charges
75

Recent inspections

  • 1311680 (NAI Tue Apr 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1219018 (NAI Fri Aug 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1170444 (VAI Thu May 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1099590 (VAI Thu Aug 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1076082 (NAI Fri Nov 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time))

Compliance actions

Other import refusals

  • AEK-4732872-7/11/1 (Tue Mar 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-3225077-9/11/1 (Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-2783875-2/11/1 (Mon Feb 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-2786470-9/11/1 (Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-8237854-4/21/1 (Fri Dec 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources